Study by Baldwin Insurance Group Reveals Companies May Be Over-Insuring D&O Coverage by Millions, Despite Declining Premium Rates

Reuters
05-29
Study by <a href="https://laohu8.com/S/BWIN">Baldwin Insurance Group</a> Reveals Companies May Be Over-Insuring D&O Coverage by Millions, Despite Declining Premium Rates

The Baldwin Insurance Group Inc., in collaboration with Nasdaq, has released its 2025 Directors & Officers (D&O) Benchmarking Report. The report offers an in-depth analysis of D&O insurance trends across public companies, segmented by industry and market capitalization. Now in its fourth year, the report highlights a continuing decline in premium rates and retentions. However, it also uncovers a significant misalignment between the coverage companies purchase and their actual risk exposure. Many firms might be over-insuring by $10 million to $20 million, as their actual risk profiles do not justify the coverage limits they are buying. The report provides granular benchmarking for premium changes, enabling companies to compare their renewal experiences with those of similar peers. Despite an overall average rate change of -9.7% for 2024, the study cautions against the potential pitfalls of misaligned coverage. The Baldwin Group emphasizes the importance of strategic capital deployment to ensure insurance spending aligns with business goals and risk exposure. For more information, visit their website at www.baldwin.com.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Baldwin Insurance Group Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250529622359) on May 29, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10